VANCOUVER, BC, Feb. 18, 2021 /CNW/ - Trading resumes in: Company: Tantalex Resources Corporation CSE Symbol: TTX All Issues: Yes Resumption (ET): 11:45 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are imp...Read More
VANCOUVER, BC, Nov. 16, 2020 /CNW/ - Trading resumes in: Company: Tantalex Resources Corporation CSE Symbol: TTX All Issues: Yes Resumption (ET): 2:00 PM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are impl...Read More
Toronto, Ontario--(Newsfile Corp. - Le 16 novembre/November 16, 2020) - Effective immediately, Tantalex Resources Corporation will be reinstated for trading. The Company has rectified the default situation that gave rise to the suspension. _________________________________...Read More
VANCOUVER, BC, Aug. 20, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Tantalex Resources Corporation CSE Symbol: TTX All Issues: No Reason: Cease Trade Order Halt Time (ET): 7:45 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a se...Read More
Toronto, Ontario--(Newsfile Corp. - le 20 août/August 2020) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. A Cease Trade Orders have been...Read More
TORONTO, ON and MUNICH, GERMANY / ACCESSWIRE / November 6, 2019 / TANTALEX Resources Corporation (CSE:TTX)(FSE:1T0) ("TANTALEX" or the "Corporation"), is pleased to announce that the Company has selected an experienced drilling contractor to begin drilling the highly pros...Read More
TORONTO and MUNICH, Germany, March 21, 2019 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation Inc. (CSE: TTX – FSE: 1T0) (“TANTALEX” or the "Company") announces the results of its special meeting of shareholders that was held on March 15, 2019 (the “Meeting&...Read More
TORONTO and MUNICH, Germany, Nov. 12, 2018 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation (CSE: TTX – FSE: 1T0) (“TANTALEX” or the “Corporation”), announces the entering into a letter of intent with International Cobalt Corp. (CSE: CO) “ICC”) w...Read More
TORONTO and MUNICH, Germany, Aug. 23, 2018 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation (CSE: TTX – FSE: 1T0) (“TANTALEX” or the “Corporation”), is pleased to announce that the contemplated transaction, previously announced in its press release dated July...Read More
TORONTO and MUNICH, Germany, July 16, 2018 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation (CSE:TTX) (FSE:1T0) (“TANTALEX” or the “Corporation”), is pleased to announce that its 90% owned subsidiary Buckell SAS (“Buckell”) has entered into an assignmen...Read More
TORONTO and MUNICH, Germany, June 12, 2018 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation (CSE:TTX) (FSE:1T0) (“TANTALEX” or the “Corporation”), announces that it has agreed to enter into various agreements pursuant to which Tantalex will settle $967,813 of debt th...Read More
TORONTO and MUNICH, Germany, April 25, 2018 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation (CSE:TTX) (FSE:1T0) (“TANTALEX” or the “Corporation”), is pleased to announce that the first hole of a 2,000-metre drilling program at its Buckell Lithium project, ha...Read More
Theralase Discovers Cannabinoid Increases Efficacy of Patented Anti-Cancer Technology in Destruction of Brain Cancer Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a clinical stage pharmaceutica...Read More
Theralase Anti-Cancer Technology Effective in Destroying Brain Cancer Stem Cells Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a clinical stage pharmaceutical company dedicated to the research...Read More
Rutherrin® Technology Granted Allowance for Canadian Patent Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a clinical stage pharmaceutical company dedicated to the research and develo...Read More
Theralase Advances Anti-Cancer Technology in Destruction of Human Lung Cancer Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQX: TLTFF), a clinical stage pharmaceutical company dedicated to the research and...Read More
TORONTO, March 01, 2018 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation (CSE:TTX) (FSE:1T0) (“TANTALEX” or the “Corporation”), announces that the board of Directors has approved, as of March 1st, 2018, the issuance of 10,800,000 options to purchase common shares...Read More
Theralase Announces Settlement Agreement with Ontario Securities Commission Toronto, Ontario (FSCwire) - Theralase Technologies Inc. (the “Company”) (TSXV: TLT) (OTCQX: TLTFF) announced today that the Company and Roger Dumoulin-White, former Chairman, President and Chief Executive O...Read More
TORONTO and MUNICH, Germany, Feb. 21, 2018 (GLOBE NEWSWIRE) -- TANTALEX Resources Corporation (CSE:TTX) (FSE:1T0) (“TANTALEX” or the “Corporation”), is pleased to announce the completion of 27 exploration pits and the receiving of assay results from the first 10 pit...Read More
TORONTO and MUNICH, Germany, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Tantalex Resources Corporation (CSE:TTX) (FSE:1T0) (“Tantalex” or the “Corporation”), is pleased to announce that it has completed a non-brokered private placement financing (the “Offering”...Read More